$84.49
0.27% yesterday
NYSE, Nov 25, 10:01 pm CET
ISIN
US3795772082
Symbol
GMED

Globus Medical, Inc. Class A Stock price

$84.49
+11.32 15.47% 1M
+18.67 28.37% 6M
+31.20 58.55% YTD
+38.42 83.39% 1Y
+17.58 26.27% 3Y
+28.16 49.99% 5Y
+61.61 269.27% 10Y
NYSE, Closing price Mon, Nov 25 2024
-0.23 0.27%
ISIN
US3795772082
Symbol
GMED
Sector

Key metrics

Market capitalization $11.50b
Enterprise Value $11.35b
P/E (TTM) P/E ratio 127.46
EV/FCF (TTM) EV/FCF 38.62
EV/Sales (TTM) EV/Sales 4.58
P/S ratio (TTM) P/S ratio 4.64
P/B ratio (TTM) P/B ratio 2.82
Revenue growth (TTM) Revenue growth 102.10%
Revenue (TTM) Revenue $2.48b
EBIT (operating result TTM) EBIT $181.20m
Free Cash Flow (TTM) Free Cash Flow $293.77m
Cash position $694.71m
EPS (TTM) EPS $0.66
P/E forward 84.85
P/S forward 4.61
EV/Sales forward 4.54
Short interest 2.82%
Show more

Is Globus Medical, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Globus Medical, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Globus Medical, Inc. Class A forecast:

10x Buy
63%
5x Hold
31%
1x Sell
6%

Analyst Opinions

16 Analysts have issued a Globus Medical, Inc. Class A forecast:

Buy
63%
Hold
31%
Sell
6%

Financial data from Globus Medical, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,479 2,479
102% 102%
100%
- Direct Costs 1,155 1,155
203% 203%
47%
1,323 1,323
56% 56%
53%
- Selling and Administrative Expenses 715 715
69% 69%
29%
- Research and Development Expense 170 170
87% 87%
7%
438 438
32% 32%
18%
- Depreciation and Amortization 257 257
184% 184%
10%
EBIT (Operating Income) EBIT 181 181
25% 25%
7%
Net Profit 92 92
42% 42%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Globus Medical, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Globus Medical, Inc. Class A Stock News

Neutral
GlobeNewsWire
4 days ago
AUDUBON, Pa., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the ExcelsiusHub™ navigation system. ExcelsiusHub™ joins the expansive ecosystem of Excelsius™ technologies and is designed to elevate the standard for freehand navigation.
Neutral
Seeking Alpha
20 days ago
Globus Medical, Inc. (NYSE:GMED ) Q3 2024 Earnings Conference Call November 5, 2024 6:00 PM ET Company Participants Brian Kearns - SVP, Business Development and IR Daniel Scavilla - President and CEO Keith Pfeil - COO and CFO Conference Call Participants Matthew Miksic - Barclays Dino Weinstock - Wells Fargo Young Li - Jefferies Shagun Singh - RBC Capital Markets Phil Dantoin - Piper Sandler Da...
Neutral
GlobeNewsWire
21 days ago
AUDUBON, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2024.
More Globus Medical, Inc. Class A News

Company Profile

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Head office United States
CEO Daniel Scavilla
Employees 5,000
Founded 2003
Website www.globusmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today